Literature DB >> 25228449

Identifying radiographic specificity for phosphatase and tensin homolog and epidermal growth factor receptor changes: a quantitative analysis of glioblastomas.

Yinyan Wang1, Xing Fan, Chuanbao Zhang, Tan Zhang, Xiaoxia Peng, Tianyi Qian, Jun Ma, Lei Wang, Shaowu Li, Tao Jiang.   

Abstract

INTRODUCTION: Phosphatase and tensin homolog (PTEN) loss and epidermal growth factor receptor (EGFR) amplification are common genetic alterations in malignant gliomas. This study aimed to investigate the anatomical relationship of tumor-related PTEN and EGFR expression in 140 patients with histologically confirmed de novo glioblastoma.
METHODS: Preoperative magnetic resonance images were retrospectively analyzed. The lesions of each patient were segmented manually and registered to a standard brain space. Overlaying of the lesions was performed, and specific brain regions associated with PTEN loss and EGFR amplification were identified by voxel-based lesion-symptom mapping analyses.
RESULTS: A cluster located in the right frontal lobe was found to be associated with high occurrence of PTEN loss, whereas a cluster in the right parietal lobe was demonstrated to be specifically associated with high occurrence of EGFR amplification. An overlap of the two clusters was observed at the posterior portion of the right parietal lobe.
CONCLUSIONS: Based on voxel-based imaging analyses, our results suggest that genetic changes during the tumorigenic process may have anatomical specificity. We hope that this identified correlation between these biomarkers and the anatomical distribution of glioblastomas will help enhance our understanding of the molecular mechanisms underlying glioblastoma development and progression.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25228449     DOI: 10.1007/s00234-014-1427-y

Source DB:  PubMed          Journal:  Neuroradiology        ISSN: 0028-3940            Impact factor:   2.804


  35 in total

Review 1.  Brain tumors.

Authors:  L M DeAngelis
Journal:  N Engl J Med       Date:  2001-01-11       Impact factor: 91.245

2.  Voxel-based lesion-symptom mapping.

Authors:  Elizabeth Bates; Stephen M Wilson; Ayse Pinar Saygin; Frederic Dick; Martin I Sereno; Robert T Knight; Nina F Dronkers
Journal:  Nat Neurosci       Date:  2003-05       Impact factor: 24.884

3.  Anatomic localization of O6-methylguanine DNA methyltransferase (MGMT) promoter methylated and unmethylated tumors: a radiographic study in 358 de novo human glioblastomas.

Authors:  Benjamin M Ellingson; Timothy F Cloughesy; Whitney B Pope; Taryar M Zaw; Heidi Phillips; Shadi Lalezari; Phioanh L Nghiemphu; Hassana Ibrahim; Kourosh M Naeini; Robert J Harris; Albert Lai
Journal:  Neuroimage       Date:  2011-10-07       Impact factor: 6.556

4.  Antiangiogenic therapy with bevacizumab in recurrent malignant gliomas: analysis of the response and core pathway aberrations.

Authors:  Wei Zhang; Xiao-guang Qiu; Bao-shi Chen; Shou-wei Li; Yun Cui; Huan Ren; Tao Jiang
Journal:  Chin Med J (Engl)       Date:  2009-06-05       Impact factor: 2.628

5.  Tumor location and growth pattern correlate with genetic signature in oligodendroglial neoplasms.

Authors:  M C Zlatescu; A TehraniYazdi; H Sasaki; J F Megyesi; R A Betensky; D N Louis; J G Cairncross
Journal:  Cancer Res       Date:  2001-09-15       Impact factor: 12.701

6.  Probabilistic radiographic atlas of glioblastoma phenotypes.

Authors:  B M Ellingson; A Lai; R J Harris; J M Selfridge; W H Yong; K Das; W B Pope; P L Nghiemphu; H V Vinters; L M Liau; P S Mischel; T F Cloughesy
Journal:  AJNR Am J Neuroradiol       Date:  2012-09-20       Impact factor: 3.825

Review 7.  Genetic pathways to primary and secondary glioblastoma.

Authors:  Hiroko Ohgaki; Paul Kleihues
Journal:  Am J Pathol       Date:  2007-05       Impact factor: 4.307

Review 8.  Epidermal growth factor receptor: a re-emerging target in glioblastoma.

Authors:  Monika E Hegi; Premnath Rajakannu; Michael Weller
Journal:  Curr Opin Neurol       Date:  2012-12       Impact factor: 5.710

Review 9.  Deregulation of the EGFR/PI3K/PTEN/Akt/mTORC1 pathway in breast cancer: possibilities for therapeutic intervention.

Authors:  Nicole M Davis; Melissa Sokolosky; Kristin Stadelman; Steve L Abrams; Massimo Libra; Saverio Candido; Ferdinando Nicoletti; Jerry Polesel; Roberta Maestro; Antonino D'Assoro; Lyudmyla Drobot; Dariusz Rakus; Agnieszka Gizak; Piotr Laidler; Joanna Dulińska-Litewka; Joerg Basecke; Sanja Mijatovic; Danijela Maksimovic-Ivanic; Giuseppe Montalto; Melchiorre Cervello; Timothy L Fitzgerald; Zoya Demidenko; Alberto M Martelli; Lucio Cocco; Linda S Steelman; James A McCubrey
Journal:  Oncotarget       Date:  2014-07-15

Review 10.  PTEN signaling pathways in glioblastoma.

Authors:  Dimpy Koul
Journal:  Cancer Biol Ther       Date:  2008-09-08       Impact factor: 4.742

View more
  6 in total

1.  MRI features can predict EGFR expression in lower grade gliomas: A voxel-based radiomic analysis.

Authors:  Yiming Li; Xing Liu; Kaibin Xu; Zenghui Qian; Kai Wang; Xing Fan; Shaowu Li; Yinyan Wang; Tao Jiang
Journal:  Eur Radiol       Date:  2017-07-28       Impact factor: 5.315

2.  Radiogenomic analysis of PTEN mutation in glioblastoma using preoperative multi-parametric magnetic resonance imaging.

Authors:  Yiming Li; Yuchao Liang; Zhiyan Sun; Kaibin Xu; Xing Fan; Shaowu Li; Zhong Zhang; Tao Jiang; Xing Liu; Yinyan Wang
Journal:  Neuroradiology       Date:  2019-06-19       Impact factor: 2.804

3.  Identifying biomarkers associated with tumor growth rate: a longitudinal preoperative magnetic resonance imaging follow-up of low-grade gliomas.

Authors:  Yukun Liu; Ziwen Fan; Shaowu Li; Xing Liu; Tao Jiang; Yinyan Wang; Lei Wang
Journal:  Ann Transl Med       Date:  2022-06

4.  Deep Learning Radiomics to Predict PTEN Mutation Status From Magnetic Resonance Imaging in Patients With Glioma.

Authors:  Hongyu Chen; Fuhua Lin; Jinming Zhang; Xiaofei Lv; Jian Zhou; Zhi-Cheng Li; Yinsheng Chen
Journal:  Front Oncol       Date:  2021-10-04       Impact factor: 6.244

5.  PTEN gene mutations correlate to poor prognosis in glioma patients: a meta-analysis.

Authors:  Feng Han; Rong Hu; Hua Yang; Jian Liu; Jianmei Sui; Xin Xiang; Fan Wang; Liangzhao Chu; Shibin Song
Journal:  Onco Targets Ther       Date:  2016-06-13       Impact factor: 4.147

Review 6.  Quantitative magnetic resonance imaging and radiogenomic biomarkers for glioma characterisation: a systematic review.

Authors:  Pohchoo Seow; Jeannie Hsiu Ding Wong; Azlina Ahmad-Annuar; Abhishek Mahajan; Nor Aniza Abdullah; Norlisah Ramli
Journal:  Br J Radiol       Date:  2018-06-29       Impact factor: 3.039

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.